Company / Operating Income per Share
AbCellera Biologics Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.73
FY2025
5-year range
-$1.08 / $0.55
FY2021-FY2025
Trend
+32.2%
vs FY2024
Sector context
#83 of 201
Health Care
What the data says
At $-0.73, AbCellera Biologics Inc.'s operating income per share ranks #83 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.73.
Based on SEC 10-K filings.
-0.73 in FY2025.
Improved from $-0.83 to $-0.73 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 201 in Health CareTop 41% of 201This company -$0.73 Sector average -$3.23
▼
+77.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 32.2% year-over-year.
- Ranks #83 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.73 | +32.2% |
| FY2024 | -$1.08 | -30.9% |
| FY2023 | -$0.83 | -250.1% |
| FY2022 | $0.55 | +3705.8% |
| FY2021 | -$0.02 | -102.6% |
| FY2020 | $0.59 | +2279.6% |
| FY2019 | -$0.03 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026